I20-I25
Conditions
Interventions
Group 1: Blood draw during emergency care/management.
Dyspnea patients: 1 blood draw within 24h after admission.
Chest pain: Blood draw within 2 hours after admission and again 6-10 hours after admis
Sponsors
Charité - Universitätsmedizin Berlin
Campus Virchow-Klinikum
Medizinische Klinik m.S. Kardiologie
Internistische Notaufnahme
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patient of full age, able to sign informed consent and was inpatient for elective PTCA - Patient has frequented emergency room due to leading symptoms chest pain and/or dyspnea
Exclusion criteria
Exclusion criteria: - Redemption of consent - Anemia < 10 g/dL - Life expectancy < 6 months - state of shock or acute disease patterrn - age under 18 years - Hospitalization according to official or judicial order
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim is the diagnostic and prognostic evaluation of biomarkers in cardiovascular diseases. Primary endpoint for diagnosis is the main hospital diagnosis as documented in the final discharge letter (documentation in the eCRF) Primary endpoint for prognosis is the 3 months mortality and re-hospitalization. | — |
Countries
Germany
Contacts
Public ContactJulia Searle
Charité Universitätsmedizin Berlin Campus Virchow Klinikum Med. Klinik m.S. Kardiologie Internistische Notaufnahme
Outcome results
None listed